Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016

SAN DIEGO, June 27, 2016 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it will host its Fourth Quarter and Full Year Fiscal 2016 investor conference call and webcast on Wednesday, June 29, 2016 at 4:30 p.m. Eastern Time.

The call and webcast will follow the release of fiscal 2016 fourth quarter and full year results.  A recorded version of the call will be available approximately two hours after the call at the Investor Relations portion of the company's website,

Interested parties can also access the archived replay of Aethlon Medical's Third Quarter Fiscal 2016 investor conference call webcast at in the investor relations section under events & presentations.

Conference Call Details

What: Aethlon's Fourth Quarter and Full Year Fiscal 2016 Investor Conference Call and Webcast

Date: Wednesday, June 29, 2016

Time: 4:30 p.m. Eastern Time

Live call: 412-317-5442

International: 844-836-8741

Audio Replay: 412-317-0088

Passcode: 10088603

About Aethlon Medical, Inc.

Aethlon Medical (Nasdaq:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer.  To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.  Additional information can be found online at or you can connect with us on Twitter, LinkedIn, Facebook and Google+.


Mike Smargiassi/Brad Edwards 
Brainerd Communicators, Inc 


To view the original version on PR Newswire, visit:

SOURCE Aethlon Medical, Inc.